02/29/2024
Salvo Health is thrilled to announce the successful closing of our latest funding round, spearheaded by City Light Capital and Human Ventures. This funding will fuel our mission to expand deployment of our wraparound GI care through partners such as gastroenterology private practices, health systems, and ACOs.
Furthermore, we are delighted to welcome both Emily Melton and Rachel Parlier to our Board of Directors. Their experience as healthcare investors and innovators will be instrumental as we drive forward our mission of enabling access to high-quality "hybrid" care for those living with chronic gut and metabolic conditions. Read more on our blog:
New York, February 29th - Salvo Health today announced the closing of a $5 million Seed Prime round led by City Light Capital and Human Ventures to expand deployment of its wraparound GI care at providers including gastroenterology private practices, health systems, and ACOs.